Understanding Polymyositis
Polymyositis is a rare autoimmune disease characterized by chronic muscle inflammation and weakness. It belongs to a group of conditions called inflammatory myopathies, which cause the immune system to attack muscle tissue. In polymyositis, the immune system mistakenly attacks muscle fibers, particularly skeletal muscles responsible for movement, leading to progressive muscle weakness, pain, and difficulty performing everyday activities. Unlike dermatomyositis, polymyositis does not typically cause a skin rash. The condition most commonly affects adults between the ages of 30 and 60 and is more prevalent in women than men. While there is no cure for polymyositis, treatment can significantly improve muscle strength, reduce inflammation, and help most people regain function and quality of life.
What Happens in Polymyositis?
In polymyositis, the immune system produces white blood cells and antibodies that infiltrate and attack healthy muscle tissue, particularly skeletal muscles. This immune attack causes chronic inflammation that damages muscle fibers, leading to muscle weakness and breakdown. The inflammation primarily affects muscles closest to the trunk of the body, including the hips, thighs, shoulders, upper arms, and neck. Over time, chronic inflammation can cause muscle fibers to deteriorate and be replaced by fat and connective tissue, leading to permanent weakness and disability if left untreated. The exact cause of polymyositis is unknown, but it is believed to result from a combination of genetic predisposition, environmental triggers such as viral infections or exposure to certain medications or toxins, and immune system dysfunction. In some cases, polymyositis may be associated with other autoimmune diseases or, rarely, with underlying cancer.
Who Gets Polymyositis?
Polymyositis can affect anyone, but certain factors increase risk. Women are affected about twice as often as men. The condition most commonly develops in adults between ages 30 and 60, though it can occur at any age. African Americans are at higher risk than other ethnic groups. People with other autoimmune diseases or a family history of autoimmune conditions may have increased risk. In some adults, particularly those over age 50, polymyositis may be associated with an underlying cancer, though this is less common than with dermatomyositis. Certain viral infections, medications, and environmental exposures may trigger the condition in genetically susceptible individuals.
Common Symptoms
Polymyositis symptoms typically develop gradually over weeks to months, though they can appear more suddenly in some cases. The hallmark feature is progressive muscle weakness. Common symptoms include:
Muscle Weakness: Progressive weakness in muscles closest to the trunk (proximal muscles), particularly in the shoulders, hips, thighs, upper arms, and neck. Difficulty rising from a seated position, climbing stairs, lifting objects, or reaching overhead. Difficulty lifting the head from a pillow or holding the head upright due to neck muscle weakness. Difficulty swallowing (dysphagia) if muscles of the throat and esophagus are affected, which can lead to choking or aspiration. Muscle weakness is typically symmetrical, affecting both sides of the body equally.
Other Muscle Symptoms: Muscle pain and tenderness, though this is less prominent than the weakness. Fatigue and general weakness. Muscle atrophy (wasting) in advanced or untreated cases.
Systemic Symptoms: Shortness of breath if breathing muscles or lungs are affected. Interstitial lung disease causing chronic cough, difficulty breathing, and decreased exercise tolerance. Heart involvement, though less common, can cause irregular heartbeat or heart failure. Joint pain and mild swelling. Low-grade fever. Weight loss. General feeling of being unwell (malaise).
Complications: Difficulty swallowing can lead to aspiration pneumonia if food or liquids enter the lungs. Respiratory muscle weakness can cause breathing difficulties. Interstitial lung disease can lead to progressive lung damage and respiratory failure if untreated.
Diagnosing Polymyositis
Diagnosis involves a combination of clinical evaluation, blood tests, imaging, electromyography, and muscle biopsy. A healthcare provider will assess muscle strength, particularly in the shoulders, hips, and neck, and review symptoms and medical history. Blood tests check muscle enzyme levels including creatine kinase (CK), aldolase, aspartate aminotransferase (AST), and alanine aminotransferase (ALT), which are elevated when muscle damage occurs.
Autoantibody tests detect myositis-specific antibodies and myositis-associated antibodies. Inflammatory markers such as erythrocyte sedimentation rate (ESR) and C-reactive protein (CRP) may be elevated. Electromyography (EMG) measures the electrical activity of muscles and can detect abnormal patterns characteristic of inflammatory myopathy. MRI scans can identify areas of muscle inflammation and edema and help guide muscle biopsy location. Muscle biopsy, where a small sample of muscle tissue is removed and examined under a microscope, is the gold standard for diagnosis and shows characteristic inflammation and muscle fiber damage. Lung function tests and chest CT scans may be performed to assess for interstitial lung disease. Cancer screening may be recommended, particularly for adults over age 50, as polymyositis can occasionally be associated with underlying malignancy.
Treatment Options
There is no cure for polymyositis, but treatment can control inflammation, improve muscle strength and function, and prevent complications. Early and aggressive treatment provides the best outcomes. Treatment plans are individualized based on disease severity and organ involvement.
Corticosteroids: High-dose prednisone or methylprednisolone is typically the first-line treatment to rapidly reduce muscle inflammation. Initial treatment usually involves high doses for several weeks to months until muscle strength improves and muscle enzyme levels normalize. Once symptoms improve, the dose is gradually reduced to the lowest effective level to minimize side effects.
Immunosuppressive Medications: Methotrexate or azathioprine is often added early in treatment or used to allow reduction of corticosteroid dose. Mycophenolate mofetil may be used for more severe or resistant cases. Cyclosporine or tacrolimus may be considered in certain situations. These medications help control inflammation and reduce the need for long-term high-dose corticosteroids.
Biologic Therapies: Intravenous immunoglobulin (IVIG) involves infusions of antibodies that can improve muscle strength, particularly when other treatments are insufficient. Rituximab, a biologic therapy that targets B cells, may be used for treatment-resistant polymyositis or when other medications are not tolerated.
Physical Therapy: Essential for maintaining and improving muscle strength, flexibility, and function. A physical therapist designs an individualized exercise program that begins gently during active disease and gradually increases as inflammation improves. Regular exercise helps prevent muscle atrophy and contractures.
Occupational Therapy: Helps people adapt daily activities, learn energy conservation techniques, and use assistive devices to maintain independence during periods of weakness.
Speech and Swallowing Therapy: May be necessary if swallowing difficulties develop to prevent aspiration and ensure adequate nutrition.
Treatment of Associated Conditions: Lung involvement may require additional immunosuppressive medications, oxygen therapy, or pulmonary rehabilitation. If cancer is detected, treating the cancer may improve polymyositis symptoms.
Lifestyle Modifications: Balanced nutrition to maintain muscle mass and overall health. Adequate rest balanced with appropriate exercise. Avoiding prolonged immobility, which can worsen muscle weakness. Sun protection, though less critical than in dermatomyositis. Calcium and vitamin D supplementation to protect bone health, especially when taking corticosteroids.
Living with Polymyositis
Polymyositis is a chronic condition that requires ongoing management and monitoring. With appropriate and timely treatment, many people experience significant improvement in muscle strength and function. Some people achieve remission, while others have a chronic course requiring long-term immunosuppressive therapy. The prognosis varies widely depending on the severity of the disease, the extent of organ involvement, the response to treatment, and how quickly treatment is initiated. Early diagnosis and aggressive treatment provide the best outcomes and can prevent permanent muscle damage and disability. Regular follow-up with a rheumatologist or neurologist is essential to monitor disease activity, adjust medications, assess for complications, and screen for treatment side effects. Physical therapy and exercise are crucial for maintaining muscle strength and preventing disability.
Adherence to prescribed medications, even when feeling better, is important to prevent disease flares. Staying informed about your condition, maintaining open communication with your healthcare team, and seeking support from family, friends, and support groups can help you successfully manage both the physical and emotional aspects of living with polymyositis.